TrialLeukemia2015

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma.

E K Mai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.